Browse this journal

Cancer Immunotherapy

Created 05 Mar 2024 | 2 articles

Edited by

Dr. Carlo Riccardi(Perugia University Medical School, Italy)

Dr. Ida Landini(University of Florence, Italy)

Dr. Enrico Mini(University of Florence, Italy)

Download citations Download PDFs Download collection
Review Article
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC)
Thierry Landre, Christos Chouaïd, Nassyma Sadaoui, Djamila Bouharati & Chérifa Taleb

Originally published in Journal of Chemotherapy, Ahead of Print

Published online: 01 Feb 2024
AbstractforClinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC) | Full Text | References | PDF (982.2 KB) | EPUB | Supplemental
  • 535 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Factors associated with immune-related thyroid dysfunction induced by PD-1/PD-L1 inhibitors in cancer patients: an observational study
Xiao-Chen Wei, Yuan-Yuan Guo, Yi Zhang, Yi-Shan Bu & Feng-Ying Zhang

Originally published in Journal of Chemotherapy, Ahead of Print

Published online: 19 Jan 2024
AbstractforFactors associated with immune-related thyroid dysfunction induced by PD-1/PD-L1 inhibitors in cancer patients: an observational study | Full Text | References | PDF (755.3 KB) | EPUB | Supplemental
  • 203 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access